These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10318668)

  • 1. Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response.
    Hennuyer N; Poulain P; Madsen L; Berge RK; Houdebine LM; Branellec D; Fruchart JC; Fiévet C; Duverger N; Staels B
    Circulation; 1999 May; 99(18):2445-51. PubMed ID: 10318668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of apo A-I gene expression by fibrates.
    Staels B; Auwerx J
    Atherosclerosis; 1998 Apr; 137 Suppl():S19-23. PubMed ID: 9694537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element.
    Vu-Dac N; Schoonjans K; Laine B; Fruchart JC; Auwerx J; Staels B
    J Biol Chem; 1994 Dec; 269(49):31012-8. PubMed ID: 7983038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates.
    Vu-Dac N; Chopin-Delannoy S; Gervois P; Bonnelye E; Martin G; Fruchart JC; Laudet V; Staels B
    J Biol Chem; 1998 Oct; 273(40):25713-20. PubMed ID: 9748239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I.
    Martin G; Duez H; Blanquart C; Berezowski V; Poulain P; Fruchart JC; Najib-Fruchart J; Glineur C; Staels B
    J Clin Invest; 2001 Jun; 107(11):1423-32. PubMed ID: 11390424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil.
    Dallongeville J; Baugé E; Tailleux A; Peters JM; Gonzalez FJ; Fruchart JC; Staels B
    J Biol Chem; 2001 Feb; 276(7):4634-9. PubMed ID: 11050100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism.
    Fruchart JC; Duriez P
    Drugs Today (Barc); 2006 Jan; 42(1):39-64. PubMed ID: 16511610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.
    Vu-Dac N; Schoonjans K; Kosykh V; Dallongeville J; Fruchart JC; Staels B; Auwerx J
    J Clin Invest; 1995 Aug; 96(2):741-50. PubMed ID: 7635967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver.
    Roglans N; Bellido A; Rodríguez C; Cabrero A; Novell F; Ros E; Zambón D; Laguna JC
    Clin Pharmacol Ther; 2002 Dec; 72(6):692-701. PubMed ID: 12496750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate.
    Ribas V; Palomer X; Roglans N; Rotllan N; Fievet C; Tailleux A; Julve J; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
    Biochim Biophys Acta; 2005 Dec; 1737(2-3):130-7. PubMed ID: 16226489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response element.
    Gervois P; Chopin-Delannoy S; Fadel A; Dubois G; Kosykh V; Fruchart JC; Najïb J; Laudet V; Staels B
    Mol Endocrinol; 1999 Mar; 13(3):400-9. PubMed ID: 10076997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrate treatment induced quantitative and qualitative HDL changes associated with an increase of SR-BI cholesterol efflux capacities in rabbits.
    Fournier N; Tuloup-Minguez V; Pourci ML; Thérond P; Jullian JC; Wien F; Leroy M; Dallongeville J; Paul JL; Leroy A
    Biochimie; 2013 Jun; 95(6):1278-87. PubMed ID: 23410672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.
    Staels B; Vu-Dac N; Kosykh VA; Saladin R; Fruchart JC; Dallongeville J; Auwerx J
    J Clin Invest; 1995 Feb; 95(2):705-12. PubMed ID: 7860752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha.
    Kockx M; Princen HM; Kooistra T
    Thromb Haemost; 1998 Dec; 80(6):942-8. PubMed ID: 9869165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of rat liver apolipoprotein A-I, apolipoprotein A-II and acyl-coenzyme A oxidase gene expression by fibrates and dietary fatty acids.
    Berthou L; Saladin R; Yaqoob P; Branellec D; Calder P; Fruchart JC; Denèfle P; Auwerx J; Staels B
    Eur J Biochem; 1995 Aug; 232(1):179-87. PubMed ID: 7556148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation.
    Duez H; Lefebvre B; Poulain P; Torra IP; Percevault F; Luc G; Peters JM; Gonzalez FJ; Gineste R; Helleboid S; Dzavik V; Fruchart JC; Fiévet C; Lefebvre P; Staels B
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):585-91. PubMed ID: 15618549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
    Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
    Berthou L; Duverger N; Emmanuel F; Langouët S; Auwerx J; Guillouzo A; Fruchart JC; Rubin E; Denèfle P; Staels B; Branellec D
    J Clin Invest; 1996 Jun; 97(11):2408-16. PubMed ID: 8647932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
    Kockx M; Gervois PP; Poulain P; Derudas B; Peters JM; Gonzalez FJ; Princen HM; Kooistra T; Staels B
    Blood; 1999 May; 93(9):2991-8. PubMed ID: 10216095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice.
    Peters JM; Hennuyer N; Staels B; Fruchart JC; Fievet C; Gonzalez FJ; Auwerx J
    J Biol Chem; 1997 Oct; 272(43):27307-12. PubMed ID: 9341179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.